Style | Citing Format |
---|---|
MLA | Ghavami M, et al.. "The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial." Heliyon, vol. 10, no. 7, 2024, pp. -. |
APA | Ghavami M, Sadeghian S, Ahmadi A, Lotfitokaldany M, Ashoorkhani M, Haji Ali Asgari F (2024). The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial. Heliyon, 10(7), -. |
Chicago | Ghavami M, Sadeghian S, Ahmadi A, Lotfitokaldany M, Ashoorkhani M, Haji Ali Asgari F. "The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial." Heliyon 10, no. 7 (2024): -. |
Harvard | Ghavami M et al. (2024) 'The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial', Heliyon, 10(7), pp. -. |
Vancouver | Ghavami M, Sadeghian S, Ahmadi A, Lotfitokaldany M, Ashoorkhani M, Haji Ali Asgari F. The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial. Heliyon. 2024;10(7):-. |
BibTex | @article{ author = {Ghavami M and Sadeghian S and Ahmadi A and Lotfitokaldany M and Ashoorkhani M and Haji Ali Asgari F}, title = {The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial}, journal = {Heliyon}, volume = {10}, number = {7}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Ghavami M AU - Sadeghian S AU - Ahmadi A AU - Lotfitokaldany M AU - Ashoorkhani M AU - Haji Ali Asgari F TI - The Effectiveness of Green Heart Application to Manage Modifiable Risk Factors of Coronary Artery Disease in Tehran Heart Center: Study Protocol for a Randomized Controlled Trial JO - Heliyon VL - 10 IS - 7 SP - EP - PY - 2024 ER - |